Endotoxin-induced alteration in the expression of leptin and β3- adrenergic receptor in adipose tissue

American Journal of Physiology - Endocrinology and Metabolism

Volumn 274, Issue 6 37-6, 1998, Pages

  Berkowitz, Dan E ^a,b   Brown, Daniel ^a   Lee, Kyoung Min ^a   Emala, Charles ^a   Palmer, David ^a   An, Ying ^a   Breslow, Michael ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Cytokine; Mice; Tumor necrosis factor

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ADENYLATE CYCLASE; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CELL PROTEIN; ENDOTOXIN; GUANOSINE TRIPHOSPHATE; INTERLEUKIN 6; ISOPRENALINE; LEPTIN; TUMOR NECROSIS FACTOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ESCHERICHIA COLI; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE DIAGNOSIS;

EID: 0031803271     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.274.6.e992     Document Type: Article

References (37)

1. Ahima, R. S., D. Prabakaran, C. Mantzoros, D. Qu, B. Lowell, E.-F. Marantos, and J. S. Flier. Role of leptin in the neuroendocrine response to fasting. Nature 381: 250-252, 1996.
2. Caro, J. F., M. K. Sinha, J. W. Kolaczynski, P. L. Zhang, and R. V. Considine. Leptin: the tale of an obesity gene. Diabetes 45: 1455-1462, 1996.
3. Cooney, R. B., S. R. Kimball, and T. C. Vary. Regulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators. Shock 7: 1-16, 1997.
4. Emala, C. W., C. Black, C. Curry, M. A. Levine, and C. A. Hirshman. Impaired β-adrenergic receptor activation of adenylyl cyclase in airway smooth muscle in the basenji-greyhound dog model of airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 8: 668-675, 1993.
5. Emala, C. W., J. Kuhl, C. L. Hungerford, and C. A. Hirshman. TNF-α inhibits isoproterenol-stimulated adenylyl cyclase activity in cultured airway smooth muscle cells. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L644-L650, 1997.
6. Faggioni, R., J. Fuller, A. Moser, K. R. Feingold, and C. Grunfeld. LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R181-R186, 1997.
7. 3-adrenergic receptor in 3T3-F442A adipocytes. J. Biol. Chem. 270: 10952-10959, 1995.
8. Fredrix, E. W. H. M., P. B. Soeters, E. F. M. Wouters, I. M. Deerenberg, M. F. von Meyenfeldt, and W. H. M. Saris. Effect of different tumor types on resting energy expenditure. Cancer Res. 51: 6138-6141, 1991.
9. Friedman, J. M. The alphabet of weight control. Nature 9: 119-120, 1997.
10. Grunfeld, C., and K. R. Feingold. Metabolic disturbances and wasting in the acquired immuodeficiency syndrome. N. Engl. J. Med. 327: 329-337, 1992.
11. Grunfeld, C., R. Gulli, A. H. Moser, L. A. Gavin, and K. R. Feingold. Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J. Lipid Res. 30: 579-585, 1989.
12. Grunfeld, C., M. Pang, J. K Shigenaga, P. Jensen, R. Lallone, J. Friedman, and K. R. Feingold. Serum leptin levels in the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 81: 4342-4346, 1996.
13. Grunfeld, C., C. Zhao, J. Fuller, A. Pollack, A. Moser, J. Friedman, and K. R. Feingold. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest. 97: 2152-2157, 1996.
14. Hotamisligil, G. S., P. Arner, J. F. Caro, R. L. Atkinson, and B. M. Spiegelman. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95: 2409-2415, 1995.
15. Hotamisligil, G. S., A. Budavari, D. Murray, and B. M. Spiegelman. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 94: 1543-1549, 1994.
16. Hotamisligil, G. S., D. L. Murray, L. N. Choy, and B. M. Spiegelman. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA 91: 4854-4858, 1994.
17. Kirchgessner, T. G., K. T. Uysai, S. M. Weisbrock, M. W. Marino, and G. S. Hotamisligil. Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J. Clin. Invest. 100: 2777-2782, 1997.
18. 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J. 10: 3721-3727, 1991.
19. Oliff, A., D. Defeo-Jones, M. Boyer, D. Martinez, D. Kiefer, G. Vuocolo, A. Wolfe, and S. H. Socher. Tumors secreting human cachectin/TNF induce cachexia in mice. Cell 50: 555-563, 1987.
20. Patton, J. S., H. M. Shepard, H. Wilking, G. Lewis, B. B. Aggarwal, T. E. Eessalu, L. A. Gavin, and C. Grunfeld. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc. Natl. Acad. Sci. USA 83: 8313-8317, 1986.
21. 1-adrenergic receptor subtypes in human tissue: implications for human α-adrenergic physiology. Mol. Pharmacol. 45: 171-175, 1994.
22. 3-adrenoceptor in the regulation of body composition. J. Clin. Invest. 100: 1098-1106, 1997.
23. Shakhov, A. N., and S. A. Nedospasov. Molecular cloning of the gene encoding for tumor necrosis factors: complete nucleotide sequence of the genomic copy of TNF-α in mice. Bioorg. Khim. 13: 701-705, 1987.
24. Salomon, Y., C. Londos, and M. Rodbell. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58: 541-548, 1974.
25. Sarraf, P., R. C. Fredrich, E. M. Turner, N. T. Jaskowiak, D. J. Rivet, J. S. Flier, B. B. Lowell, D. L. Fraker, and H. R. Alexander. Multiple cytokines and acute inflammation raise mouse leptin levels - potential role in inflammatory anorexia. J. Exp. Med. 185: 171-175, 1997.
26. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85, 1985.
27. Spiegelman, B. M., and J. S. Flier. Adipogenesis and obesity: rounding out the big picture. Cell 87: 377-389, 1996.
28. Spiegelman, B. M., and G. S. Hotamisligil. Through thick and thin: wasting, obesity, and TNF alpha. Cell 73: 625-627, 1993.
29. Stephens, J. M., and P. H. Pekala. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J. Biol. Chem. 266: 21839-21845, 1991.
30. Stouthard, J. M. L., J. N. Romijn, T. van der Poll, E. Endert, S. Klein, P. J. M. Bakker, C. H. N. Veenhof, and H. P. Sauerwein. Endocrinologic and metabolic effects of interleukin-6 in humans. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E813-E819, 1995.
31. 3-adrenoceptor. Trends Pharmacol. Sci. 17: 373-381, 1996.
32. Susulic, V. S., R. C. Frederich, J. Lawitts, E. Tozzo, B. B. Kahn, M. E. Harper, J. Himms-Hagen, J. S. Flier, and B. B. Lowell. Targeted disruption of the beta 3-adrenergic receptor gene. J. Biol. Chem. 270: 29483-29492, 1995.
33. Tisdale, M. J. Cancer cachexia. Anticancer Drugs 4: 115-125, 1993.
34. Tisdale, M. J. Cancer cachexia - metabolic alterations and clinical manifestations. Nutrition 13: 1-7, 1997.
35. Yarasheski, K. E., J. J. Zachwieja, M. M. Horgan, W. G. Powderly, J. V. Santiago, and M. Landt. Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity. Metabolism 46: 303-305, 1997.
36. 3-adrenoceptor agonist, in yellow KK mice. Life Sci. 54: 491-498, 1994.
37. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-431, 1994.